Large language model AI chatbots require approval as medical devices

被引：77
作者：
Gilbert, Stephen [1 ]
Harvey, Hugh [2 ]
Melvin, Tom [3 ]
Vollebregt, Erik [4 ]
Wicks, Paul [5 ]
机构：
[1] Tech Univ Dresden, Else Kroner Fresenius Ctr Digital Hlth, Dresden, Germany
[2] Hardian Hlth, Haywards Heath, England
[3] Univ Dublin, Trinity Coll, Sch Med, Dublin, Ireland
[4] Axon Lawyers, Amsterdam, Netherlands
[5] Wicks Digital Hlth, Advantage House, Lichfield, England
来源：
NATURE MEDICINE | 2023年 / 29卷 / 10期
关键词：
D O I：
10.1038/s41591-023-02412-6
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Chatbots powered by artificial intelligence used in patient care are regulated as medical devices, but their unreliability precludes approval as such.
引用
收藏
页码：2396 / 2398
页数：3
相关论文
共 14 条
  • [1] [Anonymous], 2017, Official Journal of the European Union
  • [2] Dawes R., 2020, AINEWS
  • [3] Dorfman S., 2019, PM360
  • [4] Ingram David, 2023, NBC News
  • [5] Considering the possibilities and pitfalls of Generative Pre-trained Transformer 3 (GPT-3) in healthcare delivery
    Korngiebel, Diane M.
    Mooney, Sean D.
    [J]. NPJ DIGITAL MEDICINE, 2021, 4 (01)
  • [6] Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine
    Lee, Peter
    Bubeck, Sebastien
    Petro, Joseph
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (13) : 1233 - 1239
  • [7] Roose K, 2022, The New York Times
  • [8] Singhal K., 2022, ARXIV, DOI DOI 10.48550/ARXIV.2212.13138
  • [9] Stokel-Walker Chris, 2023, Nature, DOI 10.1038/d41586-023-00423-4
  • [10] Stokel-Walker C, 2023, NATURE, V614, P214, DOI 10.1038/d41586-023-00340-6
12